Le Lézard
Classified in: Tourism and vacations, Environment, Transportation, Business, Covid-19 virus
Subject: RCN

Toray Composite Materials America, Inc. Implements Operational Reductions and Restructuring


TACOMA, Wash., June 5, 2020 /PRNewswire/ -- Toray Composite Materials America, Inc. (CMA) is announcing a realignment of US operations and a corresponding reduction in headcount to better position for an extended downturn in its commercial business streams. 

CMA will immediately suspend operations in its Spartanburg, SC plant and significantly reduce capacity in its Tacoma, WA prepreg facility.  These actions will result in a reduction of roughly 25% of the workforce across CMAs facilities in the United States. 

"Decisions that directly impact our associates and their livelihood are never ones that we take casually," said Dennis Frett ? President and CEO.  "But, these actions are absolutely necessary to reduce our costs and position the company for the future," said Frett.  

Due to COVID-19 and the corresponding collapse of global air travel, demand for passenger aircraft has been significantly reduced.  Furthermore, global macro-economic conditions are reducing the demand for industrial products. "Considering industry analysts and recent actions by other aerospace companies, we see a three-to-five-year timeline until we return to a sales volume that resembles anything pre-pandemic," says Timothy Kirk ? Vice President of Aerospace Sales.   

These urgent actions will enable CMA to reduce its costs to partially mitigate the immediate downturn in business.  Additionally, CMA will enhance its cooperation with business units in the United States to better meet customer expectations and adapt to a changing market. 

For more information on CMA, visit www.toraycma.com.

 

SOURCE Toray Composite Materials America, Inc.


These press releases may also interest you

at 02:05
AstraZeneca: Revenue and EPS summary     Q1 2024 % Change $m Actual CER1 - Product Sales 12,177 15 18 - Alliance Revenue   457 59 59...

at 02:00
Hemogenyx Pharmaceuticals plc (LSE:HEMO), the biopharmaceutical group developing new therapies and treatments for blood...

at 01:05
Teck Resources Limited (Teck) today announced its unaudited first quarter results for 2024. "All outstanding major construction at our QB operation was completed in the first quarter, including the shiploader and molybdenum plant, and we marked the...

24 avr 2024
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the Drug...

24 avr 2024
Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB B) ("Genomma" or "the Company"), today announced its results for the first quarter of 2024. All figures included herein are stated in nominal Mexican pesos and have been prepared in accordance with...

24 avr 2024
The First Bancshares, Inc. ("FBMS" or "the Company") , holding company for The First Bank, (www.thefirstbank.com) reported today financial results for the quarter ended March 31, 2024. Highlights for the Quarter: Net income available to common...



News published on and distributed by: